# AB-2004 in Treatment of Irritability Associated With Autism Spectrum Disorder (ASD)

> **NCT04895215** · PHASE2 · COMPLETED · sponsor: **Vertero Therapeutics** · enrollment: 156 (actual)

## Conditions studied

- Autism Spectrum Disorder (ASD)

## Interventions

- **DRUG:** AB-2004
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04895215
- **Lead sponsor:** Vertero Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-02
- **Primary completion:** 2023-11-15
- **Final completion:** 2023-12-15
- **Target enrollment:** 156 (ACTUAL)
- **Last updated:** 2025-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04895215

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04895215, "AB-2004 in Treatment of Irritability Associated With Autism Spectrum Disorder (ASD)". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT04895215. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*